Table 1.
Baseline characteristics of patients with major and non-major adverse cardiovascular events.
| Variables | MACE group (n = 166) | Non-MACE group (n = 376) | p value |
| Age (year) | 64.13 14.42 | 59.73 13.29 | 0.001 |
| Male [n (%)] | 130 (78.3%) | 305 (81.1%) | 0.450 |
| Smoking [n (%)] | 86 (51.8%) | 215 (57.2%) | 0.246 |
| Hypertension [n (%)] | 104 (62.7%) | 206 (54.8%) | 0.088 |
| Diabetes [n (%)] | 48 (28.9%) | 95 (25.3%) | 0.374 |
| SP (mmHg) | 124.92 26.54 | 128.28 23.00 | 0.136 |
| DP (mmHg) | 75.03 16.01 | 78.12 15.70 | 0.036 |
| HR | 81.13 22.02 | 77.43 15.04 | 0.023 |
| Neutrophil (109/L) | 8.48 (6.14, 11.28) | 6.64 (4.93, 8.79) | 0.001 |
| Lymphocyte (109/L) | 1.30 (0.98, 1.84) | 1.52 (1.08, 2.14) | 0.013 |
| Monocyte (109/L) | 0.60 (0.42, 0.88) | 0.50 (0.39, 0.70) | 0.001 |
| Platelet (109/L) | 195.00 (157.00, 241.25) | 196.00 (153.25, 236.00) | 0.421 |
| LnPIV | 6.60 0.98 | 5.95 0.84 | 0.001 |
| LnSII | 7.09 0.80 | 6.69 0.73 | 0.001 |
| LnPLR | 4.97 0.55 | 4.82 0.51 | 0.002 |
| LnNLR | 1.82 0.76 | 1.45 0.70 | 0.001 |
| BUN (mmol/L) | 6.35 (4.91, 8.06) | 5.30 (4.33, 6.39) | 0.001 |
| Creatinine (μmol/L) | 76.00 (61.95, 99.08) | 70.80 (58.50, 79.25) | 0.001 |
| eGFR (mL/(min 1.73 m2)) | 90.49 (66.66, 101.13) | 97.53 (83.62, 106.78) | 0.001 |
| UA (mmol/L) | 361.46 (305.00, 433.10) | 347.80 (289.05, 405.85) | 0.027 |
| TP (g/L) | 62.95 (59.60, 66.10) | 62.85 (59.73, 66.58) | 0.709 |
| TG (mmol/L) | 1.43 (0.95, 2.05) | 1.52 (1.08, 2.27) | 0.053 |
| TC (mmol/L) | 4.16 (3.55, 4.82) | 4.41 (3.80, 5.11) | 0.008 |
| Gensini Score | 70.00 (44.00, 93.00) | 62.00 (42.00, 84.00) | 0.021 |
| LVEF | 58.90 (52.00, 62.00) | 59.00 (56.00, 63.75) | 0.005 |
| LVFS | 30.40 (28.00, 32.00) | 30.40 (29.00, 33.00) | 0.020 |
| Killip Class 2–4 [n (%)] | 80 (48.2%) | 78 (20.7%) | 0.001 |
Continuous variables are expressed as the mean SD, and categorical variables are expressed as percentages. The PIV, SII, PLR, and NLR are skewed data, and natural logarithmic transformations are normally distributed data.
SP, systolic blood pressure; DP, diastolic blood pressure; HR, heart rate; SD, standard deviation; MACE, major adverse cardiovascular event; LnPIV, natural logarithmic transformation of pan-immune-inflammation values; LnSII, natural logarithmic transformation of systemic immune-inflammation index; LnPLR, natural logarithmic transformation of platelet-to-lymphocyte ratio; LnNLR, natural logarithmic transformation of neutrophil-to-lymphocyte ratio; BUN, blood urea nitrogen; eGFR, glomerular filtration rate; UA, uric acid; TP, total protein; TG, triglyceride; TC, cholesterol; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening.